Banco Bilbao Vizcaya Argentaria S.A. Increases Stock Holdings in Stryker Corporation $SYK

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Banco Bilbao Vizcaya Argentaria S.A. lifted its holdings in shares of Stryker Corporation (NYSE:SYK - Free Report) by 11.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 61,466 shares of the medical technology company's stock after acquiring an additional 6,431 shares during the period. Banco Bilbao Vizcaya Argentaria S.A.'s holdings in Stryker were worth $22,895,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of SYK. Capital A Wealth Management LLC purchased a new position in shares of Stryker during the fourth quarter worth approximately $26,000. Goodman Advisory Group LLC purchased a new position in shares of Stryker during the first quarter worth approximately $32,000. City Holding Co. grew its position in shares of Stryker by 528.6% during the first quarter. City Holding Co. now owns 88 shares of the medical technology company's stock worth $33,000 after acquiring an additional 74 shares during the last quarter. Smallwood Wealth Investment Management LLC purchased a new position in shares of Stryker during the first quarter worth approximately $40,000. Finally, Itau Unibanco Holding S.A. purchased a new position in shares of Stryker during the fourth quarter worth approximately $42,000. 77.09% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on SYK shares. Citigroup restated a "buy" rating and set a $455.00 target price (up from $443.00) on shares of Stryker in a research report on Thursday, May 22nd. Roth Mkm raised their target price on shares of Stryker from $405.00 to $456.00 and gave the stock a "buy" rating in a research report on Friday, May 2nd. JMP Securities reaffirmed a "market perform" rating on shares of Stryker in a report on Monday, May 5th. Wells Fargo & Company increased their price target on Stryker from $435.00 to $445.00 and gave the stock an "overweight" rating in a report on Friday, August 1st. Finally, Truist Financial set a $415.00 price target on Stryker and gave the stock a "hold" rating in a report on Monday, August 4th. Four investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $430.10.

Stryker Price Performance

Shares of NYSE SYK opened at $381.91 on Tuesday. The firm has a market capitalization of $146.01 billion, a P/E ratio of 50.58, a PEG ratio of 2.78 and a beta of 0.91. Stryker Corporation has a one year low of $329.16 and a one year high of $406.19. The company's fifty day moving average is $386.77 and its two-hundred day moving average is $379.38. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.06 and a current ratio of 1.78.

Stryker (NYSE:SYK - Get Free Report) last issued its earnings results on Thursday, July 31st. The medical technology company reported $3.13 EPS for the quarter, topping the consensus estimate of $3.07 by $0.06. The company had revenue of $6.02 billion for the quarter, compared to analyst estimates of $5.92 billion. Stryker had a net margin of 12.25% and a return on equity of 23.94%. The business's revenue was up 11.1% on a year-over-year basis. During the same period in the previous year, the firm earned $2.81 EPS. Analysts forecast that Stryker Corporation will post 13.47 EPS for the current fiscal year.

Stryker Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be paid a dividend of $0.84 per share. This represents a $3.36 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Tuesday, September 30th. Stryker's payout ratio is 44.50%.

Insider Activity

In other news, Director Ronda E. Stryker sold 200,000 shares of Stryker stock in a transaction on Wednesday, August 6th. The stock was sold at an average price of $376.45, for a total transaction of $75,290,000.00. Following the completion of the transaction, the director owned 3,222,108 shares of the company's stock, valued at $1,212,962,556.60. The trade was a 5.84% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. 5.90% of the stock is owned by company insiders.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.